Literature DB >> 18830877

Umbelliferone aminoalkyl derivatives as inhibitors of human oxidosqualene-lanosterol cyclase.

Simonetta Oliaro-Bosso1, Silvia Taramino, Franca Viola, Silvia Tagliapietra, Giuseppe Ermondi, Giancarlo Cravotto, Gianni Balliano.   

Abstract

Human and murine lanosterol synthases (EC 5.4.99.7) were studied as targets of a series of umbelliferone aminoalkyl derivatives previously tested as inhibitors of oxidosqualene cyclases from other eukaryotes. Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human lanosterol synthase, incubated with radiolabeled oxidosqualene. In cell cultures of both human keratinocytes and mouse 3T3 fibroblasts, the observed inhibition of cholesterol biosynthesis was selective for oxidosqualene cyclase. The most active compounds bear an allylmethylamino chain in position-7 of the coumarin ring. The inhibition was critically dependent on the position and length of the inhibitor side chain, as well as on the type of aminoalkyl group inserted at the end of the same chain. Molecular docking analyses, carried out to clarify details of inhibitors/enzyme interactions, proved useful to explain the observed differences in inhibitory activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18830877     DOI: 10.1080/14756360802318688

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts.

Authors:  Silvia Taramino; Brian Teske; Simonetta Oliaro-Bosso; Martin Bard; Gianni Balliano
Journal:  Biochim Biophys Acta       Date:  2010-07-24

2.  Characterization of the channel constriction allowing the access of the substrate to the active site of yeast oxidosqualene cyclase.

Authors:  Simonetta Oliaro-Bosso; Giulia Caron; Silvia Taramino; Giuseppe Ermondi; Franca Viola; Gianni Balliano
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

3.  Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.

Authors:  Fabiana Gomes Nascimento Soares; Gabriela Göethel; Luciano Porto Kagami; Gustavo Machado das Neves; Elisa Sauer; Estefania Birriel; Javier Varela; Itamar Luís Gonçalves; Gilsane Von Poser; Mercedes González; Daniel Fábio Kawano; Fávero Reisdorfer Paula; Eduardo Borges de Melo; Solange Cristina Garcia; Hugo Cerecetto; Vera Lucia Eifler-Lima
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-19       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.